{"id":"W2908397509","doi":"10.1016/j.diabet.2018.12.001","title":"Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials","year":2019,"lang":"en","type":"review","venue":"Diabetes & Metabolism","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":282,"is_retracted":false,"has_abstract":false,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Semaglutide; Medicine; Type 2 diabetes; Exenatide; Diabetes mellitus; Glycemic; Internal medicine; Weight loss; Clinical trial; Endocrinology; Liraglutide; Obesity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001156446,0.001155731,0.01077325,0.0003130145,0.000118511,0.00009965876,0.0005011634,0.0002719658,0.00004020828],"category_scores_gemma":[0.0002007702,0.0004703525,0.001799466,0.0007952736,0.0003157713,0.0000731131,0.0001109738,0.0003441275,0.00006001038],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001770931,"about_ca_system_score_gemma":0.0002401185,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001449794,"about_ca_topic_score_gemma":0.00003728926,"domain_scores_codex":[0.9939371,0.002147259,0.001451952,0.0009058371,0.0008631208,0.000694758],"domain_scores_gemma":[0.991434,0.005641439,0.0007338325,0.00191279,0.0001469427,0.0001309729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002624875,0.001784253,0.003129505,0.003459133,0.04619703,0.0001468769,0.004459366,0.00003524049,0.000002205274,0.000589899,0.0005087247,0.9394253],"study_design_scores_gemma":[0.00478152,0.001244646,0.006064112,0.002923888,0.0466236,0.000001887423,0.0005767145,0.00001196363,0.00001359056,0.00005533521,0.937221,0.0004817716],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.07729567,0.9134859,9.410503e-7,0.0001635568,0.0003348656,0.00787134,0.0001999509,0.00003658273,0.0006111689],"genre_scores_gemma":[0.01055515,0.9869188,0.0001014349,0.0002031506,0.0002852798,0.0004413568,0.0007541306,0.0000904827,0.0006501798],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9389435,"threshold_uncertainty_score":0.9997748,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06618877307589104,"score_gpt":0.3278524107480341,"score_spread":0.2616636376721431,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}